Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › ICL Group Ltd. (ICL) Stock Forecast & Price Prediction Israel | NYSE | Basic Materials | Agricultural Inputs
$6.38
+0.04 (0.63%)10 Quality Stocks Worth Considering Now
Researching ICL (ICL) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ICL and similar high-potential opportunities.
Based on our analysis of 5 Wall Street analysts, ICL has a neutral consensus with a median price target of $6.75 (ranging from $5.80 to $7.00). The overall analyst rating is Buy (6.0/10). Currently trading at $6.38, the median forecast implies a 5.8% upside. This outlook is supported by 0 Buy, 4 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Benjamin Theurer at Barclays, projecting a 9.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ICL.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Mar 5, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $7.00 |
Feb 27, 2025 | BMO Capital | Joel Jackson | Market Perform | Maintains | $6.50 |
Jan 21, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Upgrade | $6.00 |
Aug 16, 2024 | Barclays | Benjamin Theurer | Underweight | Maintains | $4.00 |
Mar 1, 2024 | Barclays | Benjamin Theurer | Underweight | Maintains | $4.50 |
Jan 12, 2024 | Barclays | Benjamin Theurer | Underweight | Downgrade | $4.00 |
Nov 14, 2023 | Barclays | Benjamin Theurer | Overweight | Upgrade | $6.50 |
Jul 19, 2023 | Morgan Stanley | Nigel Dally | Equal-Weight | Reiterates | $7.00 |
Jun 1, 2023 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $7.00 |
May 30, 2023 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $7.00 |
May 12, 2023 | BMO Capital | Joel Jackson | Market Perform | Maintains | $8.00 |
Apr 14, 2023 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $8.00 |
Apr 12, 2023 | Morgan Stanley | Nigel Dally | Equal-Weight | Maintains | $7.50 |
Jan 27, 2023 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $10.00 |
Jan 11, 2023 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $8.50 |
Nov 17, 2022 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $11.00 |
Nov 10, 2022 | BMO Capital | Joel Jackson | Market Perform | Maintains | $9.50 |
Jul 28, 2022 | BMO Capital | Joel Jackson | Market Perform | Maintains | $11.00 |
Jun 1, 2022 | Barclays | Equal-Weight | Initiates | $0.00 | |
May 12, 2022 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $12.00 |
The following stocks are similar to ICL based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ICL Group Ltd. has a market capitalization of $8.38B with a P/E ratio of 20.6x. The company generates $6.87B in trailing twelve-month revenue with a 5.7% profit margin.
Revenue growth is +1.8% quarter-over-quarter, while maintaining an operating margin of +10.5% and return on equity of +7.3%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Produces specialty minerals and chemicals.
ICL Group Ltd. generates revenue by developing, producing, and marketing a wide range of specialty minerals and chemicals, primarily focusing on potash, phosphate, and bromine products. These products are essential in fertilizers, which enhance agricultural productivity, as well as in various industrial applications, creating a diverse income stream across multiple sectors.
Headquartered in Tel Aviv, Israel, ICL Group operates in multiple regions including Europe, North and South America, and Asia. The company is committed to sustainable practices and innovative development, positioning itself as a leader in addressing challenges related to natural resource scarcity.
Basic Materials
Agricultural Inputs
12,349
Mr. Elad Aharonson
Israel
2014
ICL Group (ICL) delivered earnings and revenue surprises of 12.50% and 0.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Israel Corporation Ltd. (TASE: ILCO) reported its first quarter results for the period ending March 31, 2025, on May 21, 2025. Further details on performance were not provided.
ILCO's Q1 results provide insights into its financial health and performance, potentially influencing stock valuation and investment decisions in the company and related sectors.
ICL reported increased sales in Q1 for its Industrial Products, Phosphate Solutions, and Growing Solutions units.
Increased sales in key business units indicate strong demand and revenue growth potential, positively impacting ICL's financial performance and investor confidence.
ICL Group Ltd will host its Q1 2025 Earnings Conference Call on May 19, 2025, at 4:00 AM ET, featuring executives including CEO Elad Aharonson and CFO Aviram Lahav.
The Q1 2025 earnings call for ICL Group Ltd will provide insights into the company's financial performance, strategic direction, and potential market impacts, influencing investor sentiment and stock valuation.
ICL reported Q1 2025 sales of $1.8 billion, up from $1.7 billion year-over-year. Operating income decreased to $185 million from $203 million, with adjusted operating income at $208 million.
ICL's revenue growth signals strong demand, but declining operating income may indicate rising costs or competitive pressures, affecting profitability and future performance outlook.
ICL Group (ICL) reported quarterly earnings of $0.09 per share, surpassing the Zacks Consensus Estimate of $0.08. Earnings are unchanged from the same quarter last year.
ICL Group's earnings beat expectations, indicating strong performance and potential for growth, which can positively influence investor sentiment and stock price.
ICL Group is expected to potentially exceed earnings estimates in its upcoming report, driven by favorable key ingredient combinations.
ICL Group's potential earnings beat signals strong performance ahead, which may positively influence stock price and investor sentiment. Monitoring expectations can guide investment decisions.
Based on our analysis of 5 Wall Street analysts, ICL Group Ltd. (ICL) has a median price target of $6.75. The highest price target is $7.00 and the lowest is $5.80.
According to current analyst ratings, ICL has 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.38. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ICL stock could reach $6.75 in the next 12 months. This represents a 5.8% increase from the current price of $6.38. Please note that this is a projection by Wall Street analysts and not a guarantee.
ICL Group Ltd. generates revenue by developing, producing, and marketing a wide range of specialty minerals and chemicals, primarily focusing on potash, phosphate, and bromine products. These products are essential in fertilizers, which enhance agricultural productivity, as well as in various industrial applications, creating a diverse income stream across multiple sectors.
The highest price target for ICL is $7.00 from Benjamin Theurer at Barclays, which represents a 9.7% increase from the current price of $6.38.
The lowest price target for ICL is $5.80 from at , which represents a -9.1% decrease from the current price of $6.38.
The overall analyst consensus for ICL is neutral. Out of 5 Wall Street analysts, 0 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $6.75.
Stock price projections, including those for ICL Group Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.